VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 94 filers reported holding VBI VACCINES INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,980 | +3.2% | 85,744 | +33.2% | 0.00% | 0.0% |
| Q4 2022 | $25,182 | -53.4% | 64,387 | -15.5% | 0.00% | -50.0% |
| Q3 2022 | $54,000 | -19.4% | 76,210 | -6.6% | 0.00% | 0.0% |
| Q2 2022 | $67,000 | -48.5% | 81,592 | +4.5% | 0.00% | -33.3% |
| Q1 2022 | $130,000 | -30.5% | 78,048 | +0.3% | 0.00% | -25.0% |
| Q4 2021 | $187,000 | -30.2% | 77,793 | -10.2% | 0.00% | -20.0% |
| Q3 2021 | $268,000 | -52.0% | 86,656 | -42.2% | 0.01% | -44.4% |
| Q2 2021 | $558,000 | +21.6% | 149,945 | -3.7% | 0.01% | +12.5% |
| Q1 2021 | $459,000 | -35.4% | 155,649 | -33.9% | 0.01% | -50.0% |
| Q4 2020 | $711,000 | -8.3% | 235,465 | -9.5% | 0.02% | -36.0% |
| Q3 2020 | $775,000 | +267.3% | 260,158 | +285.8% | 0.02% | +257.1% |
| Q2 2020 | $211,000 | – | 67,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |